How does Tecfidera (dimethyl fumarate) treat multiple sclerosis?
Tecfidera treats multiple sclerosis (MS) by reducing inflammation and calming the immune system activity that drives damage in MS. It is taken as an oral disease-modifying therapy, meaning it is designed to lower the frequency of MS relapses and slow disease activity rather than relieve symptoms immediately. [1]
What does Tecfidera do in the body?
Tecfidera (dimethyl fumarate) works by influencing immune-cell signaling and cellular stress pathways. In MS, that translates to less immune attack on the central nervous system and fewer new inflammatory lesions forming in the brain and spinal cord. [1]
Does Tecfidera cure MS or just reduce relapses?
Tecfidera is not a cure. It helps control MS disease activity—typically by reducing relapse rates and slowing progression—over the long term, but it does not eliminate MS. [1]
Who is Tecfidera used for?
Tecfidera is used to treat certain types of MS, including relapsing forms of the disease (such as relapsing-remitting MS). It is not positioned as a treatment for every MS subtype. [1]
What should patients expect in terms of treatment goals?
Patients on Tecfidera generally aim for fewer relapses and less new disease activity seen on scans over time. The benefit is disease control, not fast symptom relief. [1]
What are the risks or common side effects people ask about?
Common side effects reported with Tecfidera include flushing and gastrointestinal symptoms (such as nausea or stomach discomfort). As with other MS disease-modifying therapies, clinicians also monitor for safety issues during treatment. [1]
Sources
- https://www.drugs.com/tecfidera.html